Buligo in the First Quarter: Performance Fees Return, but the Credit Line Still Tests Cash Access
Buligo opened 2026 with real asset sales, performance fees and a much stronger net profit than in the comparable quarter. The harder question is whether those gains can reduce parent-level funding needs rather than only improve the income statement.
Buligo gave investors a stronger proof point in the first quarter than it had at the end of 2025: the realization market reopened, performance fees returned to the income statement, and the story is no longer built only on a presentation slide about future potential. Three assets were sold during the quarter and three more after the balance-sheet date, while management raised its 2026 expectation to ten realizations. That validates the listed GP model, because the company’s larger value is not only the volume of assets under management but the ability to convert older vintages into carried interest and cash receipts. Still, the quarter does not close the question left open after the previous annual analysis: how much of that value actually reaches the public-company layer, and how quickly. Operating cash flow was positive, but lower than in the comparable quarter, the dividend was paid after the balance-sheet date, and the credit-line balance that fell to $5 million at the end of March was back at $15 million by the approval date of the financial statements. The current read is therefore more constructive on the performance-fee engine, but still cautious on cash flexibility. The next two quarters need to show not only more sales, but also lower bridge-funding needs and no expansion in the weak-project list.
Realizations Returned, but Not Every Sale Creates the Same Value
Buligo is a U.S. real estate investment management platform that acts as general partner, organizes transactions, raises investors, manages projects and co-invests alongside investors for 3% to 6% of the equity in each transaction. The model creates three income layers: management and transaction fees, performance fees on realizations after preferred returns to investors, and returns on its own LP investments. A good quarter is therefore not measured only by net profit, but by whether realizations resume without the company needing to put too much additional capital into weak projects or draw more credit at the parent level.
In the first quarter, the company led two acquisition and development transactions totaling about $82.9 million, backed by about $33 million of investor equity, and recognized about $0.9 million of fees from arranging those deals. At the same time, it sold three assets for total proceeds of about $108.1 million and received about $2.6 million of performance fees. After the balance-sheet date, two additional acquisitions totaling about $29.6 million were completed, alongside three additional asset sales totaling about $60.8 million, of which two are expected to generate about $1.47 million of performance fees.
The gap between completed realizations and the full-year expectation matters. Two sale agreements, East Hennepin and Encore at Murrells, were cancelled during the quarter because the buyers had financing difficulties. The market is more open, but not every contract becomes a closed sale. The performance-fee stack also remains far from cash: the updated simulation shows a range of $104 million to $130 million of potential future performance fees from the current portfolio, after excluding transactions that management does not expect to generate performance fees. The prior follow-up analysis on performance fees focused on the gap between potential and actual collection. The first quarter narrows that gap, but does not eliminate it.
Profit Jumped, but Cash Still Runs Through the Credit Line
The income statement was strong. Total revenue rose to $5.923 million from $3.885 million in the comparable quarter. Fee income rose to $2.730 million, performance-fee income rose to $2.718 million, and total comprehensive profit was $1.572 million compared with only $171 thousand in the comparable quarter. But operating cash flow was $1.838 million, down from $3.535 million in the comparable quarter, mainly because the comparable quarter included cash collection from receivables and accrued income balances.
| Metric | Q1 2025 | Q1 2026 | Meaning |
|---|---|---|---|
| Fee income | $1.656 million | $2.730 million | The operating base expanded through more transactions and management fees |
| Performance-fee income | $1.665 million | $2.718 million | Realizations are reaching the income statement, not only the presentation |
| Total comprehensive profit | $0.171 million | $1.572 million | A sharp improvement, but from a very low base |
| Operating cash flow | $3.535 million | $1.838 million | Profit improved faster than cash in the quarter |
Consolidated liquidity still looks comfortable: cash and short-term deposits of about $22.2 million, current assets of $30.4 million, equity of $69.5 million and an equity-to-balance-sheet ratio of about 84%. But the question raised in the previous liquidity analysis remains relevant: how much of the cash and value is truly available at the public-company level after investments, debt, dividends and project support.
On an all-in cash flexibility basis after actual cash uses, the quarter was mixed. Before the April dividend payment, the company generated $1.838 million from operating activities, used $1.365 million in investing activities, and used $5.062 million in financing activities, mainly repayment of $5 million from the credit line. At the end of March, credit-line utilization stood at $5 million, with comfortable covenant headroom: total leverage of 0.5 versus a ceiling of 3.0, and fixed-charge coverage of 3.27 versus a minimum of 1.10. This is not a covenant stress story.
After the balance-sheet date, the picture became less clean. The $2.5 million dividend was paid on April 14, and the company drew another $10 million from the credit line. By the financial-statement approval date, utilization stood at $15 million. At the same time, the company is considering a public convertible bond issuance that, based on the draft deed, would be repaid in one payment in June 2030 and carry 3.25% annual interest. This is not an immediate liquidity warning, but it does show that the company is still looking for a better funding structure for a year of growth and realizations.
Weak Projects Still Consume Capital and Attention
The other side of the returning realization market is that the company still has weak assets. 10793 Harry Hines was sold after the balance-sheet date for about $8.6 million, with no performance fee, and the investment ended with a negative return for investors at about 0.6x equity multiple. It is the third transaction on the negative-return list since 2023, alongside Autumn Ridge and Carrer de la Cera.
The list of projects that may still generate negative investor returns explains why performance fees are not linear. At Eagle Yards, additional loans were or will be provided, occupancy remains low, and the plan to sell part of the asset has not yet been completed. At Pencil Factory, the company recorded a full impairment against the remaining loan balance. At The Tyde, the asset still faces pressure from competition and tenant concessions. At Dry Creek at East Village, the loan was extended until June 2026, the local partner provided a loan, and the company guarantees 50% of it. At The Parkwood, occupancy improved but still stood at only 46% by the report approval date, and the project is not meeting the financial undertakings under its loan agreement.
The implication is not that the whole portfolio is weak. The point is that a weak project can require another loan, more equity, another guarantee, or more management time, even while other realizations generate performance fees. At the end of March, subsidiaries had indemnity commitments to lenders in development projects and other transactions up to meaningful amounts, while the company assessed the likelihood of payment as very low because the projects were complying with loan terms. After the balance-sheet date, another indemnity commitment was added for a project with a loan of about $17.6 million, up to about $8.8 million.
The regulatory event does not change the balance sheet, but it matters for the distribution model. The Israel Securities Authority notified the company of an intention to impose a NIS 71,760 monetary sanction over an allegation that paid advertising related to private partnerships and funds exceeded the permitted general advertising exemption. The company intends to respond and argue for a reduction. The amount is small, but it is a reminder that expanding the investor base and product shelf must stay inside clear marketing and regulatory boundaries.
Conclusion
The current read on Buligo improved versus the end of 2025, mainly because realizations are no longer only a promise. Performance fees returned to the income statement, the 2026 realization expectation rose to ten assets, and the portfolio still contains a meaningful range of potential performance fees. The establishment of Buligo Fund VII, the plan to seek a strategic partner for a recapitalization of the ML senior-housing portfolio, and the examination of a real estate-backed debt fund add possible income paths, but they still need to become fees, management income and cash.
The proof is not complete. The credit line drawn back to $15 million, the post-quarter dividend payment, the contemplated convertible bond, and the weak-project list all limit how positive the interpretation should be. The company does not look covenant-stressed, but it also has not reached a point where every dollar of performance-fee profit immediately becomes free cash for shareholders.
Over the coming quarters, the market will measure Buligo through three questions: whether the company can get close to ten realizations in 2026, whether performance fees and transaction fees reduce bridge-funding needs at the company level, and whether weak projects remain isolated cases. Positive answers would make the first quarter look like the beginning of unlocking the performance-fee stack. Further credit-line use or a broader weak-project list would leave the improvement real, but less accessible to shareholders.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.